Policy

What’s the deal with the New York Blood Center?

A proposal for a high rise research facility on the Upper East Side may see the City Council buck member deference.

In these final days of Speaker Corey Johnson’s tenure, a land-use drama is playing out that’s upending city hall politics as usual.

In these final days of Speaker Corey Johnson’s tenure, a land-use drama is playing out that’s upending city hall politics as usual. John McCarten/New York City Council

Operators of the New York Blood Center want to knock down its dated facility located on East 67th Street on the Upper East Side, replacing it with a state-of-the-art facility that would also house lab space that could be leased out to other life sciences companies. But to do that, the joint project with Boston-based real estate group Longfellow required an upzoning from the city. 

Some neighborhood groups and local elected officials – including Rep. Carolyn Maloney and state Sen. Liz Krueger – opposed the project,because of the impact the sizable office building could have on the mostly residential area. Complaints included that the tower would cast a shadow on a nearby school complex and park, and bring more commercial traffic to the sidestreet. But the most important thumbs down came from New York City Council Member Ben Kallos, whose district includes the center. Due to a City Council custom known as member deference, where the rest of the Council follows the local members’ lead on land use issues, that would typically mean the project is doomed. But that doesn’t seem to be the case here, as the project cleared two important procedural hurdles on Wednesday, despite Kallos’ objections. 

In these final days of Speaker Corey Johnson’s tenure, a land-use drama is playing out that’s upending city hall politics as usual. Here’s the rundown, updated Wednesday Nov. 10.

What is the New York Blood Center?

 A nonprofit that raked in nearly $500 million in its last reported fiscal year, the New York Blood Center provides as much as 90% of the city’s blood supplies, according to reporting from Crain’s New York Business. The company’s reach goes beyond the city, serving 17 states, while also touting a genomics lab, a research institute and clinical-services programs. 

What’s being proposed?

The New York Blood Center, Inc. is looking to revamp its facility on East 67th Street into a nearly 600,000 square-foot life sciences lab. According to the application, the current facility, which had been a three-story trade school built in 1930, is antiquated. A third of the tower would go to the Blood Center, while the rest would be under Longfellow’s purview, and they would lease spaces to life science organizations. While the rezoning also consists of two residential buildings that are not owned by Blood Center, those buildings are not expected to be redeveloped, according to the city’s application.

The sticking point, however, is the proposed height of the new facility, with a tower that’ll reach 276 feet. The concern of those against the project is that it would cast a shadow. Back when the city’s planning department studied the building at its former proposed height of 334 feet, the city found that St. Catherine’s Park would receive three to four hours of new incremental shadows during the spring, summer and fall, “thereby causing a significant adverse shadow impact to the use of the park in the late afternoons in those seasons.” (Update: on Wednesday, the project was negotiated down to 218 feet at the top of the street wall, reaching up to 233 feet including mechanical space.)

Who’s for it?

Council Member Rafael Salamanca is for the rezoning, and as the chair of the land use committee, that has significant implications. Salamanca is breaking with the tradition of member deference by disagreeing with Kallos. “It’s hard to tell a nonprofit that saves lives, to say no to them, when they’re trying to increase their capacity and their research for New Yorkers,” Salamanca told Politico. “It’s hard to tell them no when your only argument is you’re concerned about the shadows in your community.” 

Along with Salamanca, the council’s Black, Latino and Asian Caucus voiced it’s support for the rezoning, another sign that the land use chair is likely to be joined by others and bypass member deference. In a statement posted on Twitter, the caucus said that the expansion of the Blood Center will yield jobs, revenue and technological advances that could help uplift historically underserved communities. “We urge all of the stakeholders involved in the negotiations over the proposal to act in good faith, operate from the baseline of understanding from which these discussions originated and find a way to get to a YES,” the caucus tweeted.

The de Blasio administration also favors the project. Health commissioner Dr. Dave Chokshi has submitted testimony in favor of the project and Vicki Been, the city’s deputy mayor for housing and urban development, has spoken to legislators to back the rezoning, according to the New York Post. The Post wrote that two firms working on the Blood Center rezoning, Kramer Levin law firm and public relations firm BerlinRosen, have been connected to de Blasio in the past.

Against it?

 Kallos has railed against the project, saying the proposal has steamrolled the community. 

“I’ve never seen a land use process anywhere in the city of New York where the developer ignored the community to this extent, and just told the community to go F themselves,” said Kallos as reported by Upper East Blog Our Town. “It’s just inappropriate. It’s horrible. And I’ve never seen anything like this. This is not how community-driven planning works. This is how profit-driven planning works.”

Kallos wasn’t alone. Four Manhattan legislators, Rep. Carolyn Maloney, state Sen. Liz Krueger, Assembly Member Rebecca Seawright and Manhattan Borough President Gale Brewer, who also opposed the project in the city’s land use review process, penned a letter expressing their opposition to the project as it stood on Nov. 4, urging the City Council to reject the developer’s “all or nothing approach.” 

But following negotiations with Johnson on Wednesday, in which the proposed building’s height was reduced and more funding was arranged for the nearby school and park, at least one changed their mind. Brewer and City Council Member Keith Powers, who represents a district half a block away from the lot in question, both signed on in support

Last-ditch effort against the project

A council subcommittee was slated to have a hearing on the rezoning on Tuesday. That was derailed, however, as a condominium board of one the neighboring buildings filed an objection to the the City Planning Commission’s approval of the rezoning (The City Planning Commission approved it in September). Their little-used objection may trigger a procedure in the City Charter requiring a three-fourths vote, or 39 of the 51 council members, to approve the project.That gave hope to Kallos, who told Patch on Monday that he doesn’t believe the council will get the votes necessary to pass the project over his objections. 

What’s next? 

The City Council’s Subcommittee on Zoning and Franchises and the Committee on Land Use approved the updated, shortened proposal on Nov. 10, apparently bucking member deference for what some observers say is the first time in more than a decade. Because of the alteration, the rezoning proposal has been kicked back to the City Planning Commission. It’s expected to be brought up for a vote before the full City Council at the next stated meeting on Nov. 23. 

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.